In order to understand the mechanism of the LPLI-mediated effects, we analyzed RAGE signaling by western blotting and found that LPLI attenuated the diabetes-induced activation of NF-κB (Figs 3 and 4), down-regulating the expression of those inflammatory markers. The gene discussed is NFKB1; the disease is diabetes mellitus.